A notable advancement in diabetes management is emerging with the release of tirzepatide at a dosage of 45mg. This innovative version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://arunmouv676005.wikikarts.com/2209329/significant_development_tirzepatide_45mg_for_blood_sugar_control